A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Tumor suprarrenal
El tratamiento primario es la extirpación quirúrgica del tumor. Es posible que el carcinoma corticosuprarrenal no responda bien a la quimioterapia. Se pueden administrar medicamentos para disminuir la producción de cortisol, que causa muchos de los síntomas.
El pronóstico depende de qué tan pronto se efectúe el diagnóstico y de si el tumor se ha diseminado (hecho metástasis) o no. Los tumores que se han diseminado generalmente llevan a la muerte en cuestión de 1 a 3 años.
El tumor se puede diseminar al hígado, al hueso, al pulmón o a otras áreas.
Consulte con el médico si usted o su hijo presenta síntomas de carcinoma corticosuprarrenal, síndrome de Cushing o insuficiencia en el crecimiento.
Lal G, O’Dorisio T, McDougall R, Weigel RJ. Cancer of the endocrine system. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, eds. Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2008:chap 75.
National Cancer Institute. Adrenocortical carcinoma treatment PDQ. Updated May 16, 2008.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885